Crinetics Pharmaceuticals, Inc.
Total Trades
109
Buys
2
Sells
77
Largest Trade
N/A
Insiders
14
Institutional Funds
195
Inst. Value
$1M+
Activist Filings
41
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Okey Stephanie | Director | SELL | $100K–$500K | 3K | $39.67 | Mar 4, 2026 |
| Schilke Tobin | CFO | SELL | $100K–$500K | 7K | $39.67 | Mar 4, 2026 |
| Kalofonos Isabel | Chief Commercial O… | EXERCISE | $100K–$500K | 3K | $40.59 | Jan 7, 2026 |
| Kalofonos Isabel | Chief Commercial O… | SELL | $100K–$500K | 3K | $55.00 | Jan 7, 2026 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $50K–$100K | 5K | $16.89 | Dec 3, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $100K–$500K | 5K | $45.02 | Dec 3, 2025 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $50K–$100K | 5K | $16.89 | Nov 5, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $100K–$500K | 5K | $42.66 | Nov 5, 2025 |
| Struthers Richard Scott | President & CEO | SELL | $100K–$500K | 4K | $45.00 | Sep 30, 2025 |
| Fust Matthew K | Director | SELL | $500K+ | 16K | $44.75 | Sep 30, 2025 |
| Fust Matthew K | Director | EXERCISE | $15K–$50K | 10K | $1.91 | Sep 30, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $100K–$500K | 5K | $32.10 | Sep 4, 2025 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $50K–$100K | 5K | $16.89 | Sep 4, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 30K | $30.43 | Aug 26, 2025 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $500K+ | 30K | $16.89 | Aug 26, 2025 |
| Betz Stephen F. | Chief Scientific O… | EXERCISE | $100K–$500K | 88K | $3.30 | Jun 16, 2025 |
| Betz Stephen F. | Chief Scientific O… | SELL | $1M+ | 97K | $32.23 | Jun 16, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $50K–$100K | 3K | $34.20 | Mar 21, 2025 |
| Knight Jeff E. | COO | SELL | $100K–$500K | 7K | $34.20 | Mar 21, 2025 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 6K | $34.20 | Mar 21, 2025 |
| Struthers Richard Scott | President & CEO | SELL | $500K+ | 17K | $34.20 | Mar 21, 2025 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 18K | $17.28 | Jan 7, 2025 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 15K | $52.09 | Jan 7, 2025 |
| Struthers Richard Scott | President & CEO | SELL | $500K+ | 10K | $57.57 | Dec 4, 2024 |
| Knight Jeff E. | COO | SELL | $15K–$50K | 501 | $56.52 | Nov 26, 2024 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 14K | $16.89 | Oct 7, 2024 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 14K | $54.63 | Oct 7, 2024 |
| Wilson Marc | CFO | SELL | $1M+ | 25K | $51.11 | Sep 30, 2024 |
| Wilson Marc | CFO | EXERCISE | $100K–$500K | 25K | $15.29 | Sep 30, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $53.19 | Aug 28, 2024 |
| Wilson Marc | CFO | SELL | $1M+ | 32K | $43.61 | Jul 2, 2024 |
| Wilson Marc | CFO | EXERCISE | $100K–$500K | 32K | $9.28 | Jul 2, 2024 |
| Knight Jeff E. | COO | SELL | $15K–$50K | 956 | $44.38 | Jun 28, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $45.37 | Jun 26, 2024 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 10K | $16.89 | Jun 25, 2024 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $100K–$500K | 10K | $45.73 | Jun 25, 2024 |
| Hassard James | Chief Commercial O… | SELL | $500K+ | 15K | $44.66 | Jun 24, 2024 |
| Hassard James | Chief Commercial O… | EXERCISE | $100K–$500K | 15K | $19.73 | Jun 24, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $43.86 | Jun 11, 2024 |
| Betz Stephen F. | Chief Scientific O… | SELL | $100K–$500K | 3K | $47.49 | May 30, 2024 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 14K | $16.89 | Apr 17, 2024 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 14K | $44.47 | Apr 17, 2024 |
| Struthers Richard Scott | President & CEO | EXERCISE | $100K–$500K | 41K | $9.28 | Apr 8, 2024 |
| Struthers Richard Scott | President & CEO | SELL | $1M+ | 41K | $49.17 | Apr 8, 2024 |
| Okey Stephanie | Director | SELL | $500K+ | 18K | $46.38 | Apr 2, 2024 |
| Okey Stephanie | Director | EXERCISE | $100K–$500K | 18K | $18.29 | Apr 2, 2024 |
| Knight Jeff E. | COO | SELL | $1M+ | 32K | $44.31 | Mar 26, 2024 |
| Knight Jeff E. | COO | EXERCISE | $500K+ | 30K | $23.98 | Mar 26, 2024 |
| Pizzuti Dana | Chief Med and Dev … | SELL | $500K+ | 15K | $44.06 | Mar 22, 2024 |
| Pizzuti Dana | Chief Med and Dev … | EXERCISE | $100K–$500K | 14K | $16.89 | Mar 22, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 195 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Point72 Asset Management, L.P. | 2.3M | $1M+ | SH |
| STATE STREET CORP | 2.2M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9M | $1M+ | SH |
| Novo Holdings A/S | 1.6M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.6M | $1M+ | SH |
| Siren, L.L.C. | 1.5M | $1M+ | SH |
| GW&K Investment Management, LLC | 1.4M | $1M+ | SH |
| JENNISON ASSOCIATES LLC | 1.2M | $1M+ | SH |
| First Light Asset Management, LLC | 1.2M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.1M | $1M+ | SH |
| ORBIMED ADVISORS LLC | 999K | $1M+ | SH |
| Candriam S.C.A. | 831K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 782K | $1M+ | SH |
| Fisher Asset Management, LLC | 759K | $1M+ | SH |
| Aberdeen Group plc | 675K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 518K | $1M+ | SH |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 408K | $1M+ | SH |
| Ikarian Capital, LLC | 369K | $1M+ | SH (Put) |
| ADAR1 Capital Management, LLC | 309K | $1M+ | SH |
| ADAR1 Capital Management, LLC | 309K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Farallon Capital Partners, L.P.
SC 13G/A · Feb 5, 2026
0.6%
585K shares
Wellington Management Group LLP
SC 13G/A · Nov 12, 2025
8.9%
8.4M shares
Farallon Capital Partners, L.P.
SC 13G · Sep 8, 2025
0.4%
398K shares
Wellington Management Group LLP
SC 13G/A · Aug 12, 2025
6.2%
5.8M shares
SC 13G/A · May 12, 2025
15.0%
14.0M shares
SC 13G/A · Apr 7, 2025
10.0%
9.3M shares
Wellington Management Group LLP
SC 13G/A · Feb 10, 2025
7.5%
7.0M shares
SC 13G/A · Feb 7, 2025
10.4%
9.6M shares
SC 13G/A · Feb 7, 2025
9.6%
8.9M shares
SC 13G/A · Jan 31, 2025
9.8%
9.1M shares
Point72 Asset Management, L.P.
SC 13G/A · Nov 15, 2024
2.9%
2.3M shares
SC 13G/A · Nov 14, 2024
4.8%
4.3M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Nov 14, 2024
6.2%
4.9M shares
SC 13G/A · Nov 12, 2024
7.8%
6.3M shares
Wellington Management Group LLP
SC 13G · Nov 8, 2024
5.6%
4.5M shares
SC 13G/A · Nov 4, 2024
7.8%
6.3M shares
STATE STREET CORPORATION 04-2456637
SC 13G/A · Oct 17, 2024
3.6%
2.8M shares
SC 13G · Mar 11, 2024
5.3%
4.2M shares
SC 13D/A · Mar 2, 2024
148.9M shares
SC 13G/A · Feb 14, 2024
2.5%
1.7M shares
Point72 Asset Management, L.P.
SC 13G/A · Feb 14, 2024
5.1%
3.4M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2024
0.0%
0 shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G/A · Feb 14, 2024
7.5%
5.0M shares
The Vanguard Group - 23-1945930
SC 13G · Feb 13, 2024
5.2%
3.5M shares
SC 13G/A · Jan 25, 2024
8.0%
5.3M shares
STATE STREET CORPORATION I.R.S. IDENTIFICATION NO. OF THE ABOVE PERSON 04-2456637
SC 13G · Jan 24, 2024
5.3%
0 shares
Point72 Asset Management, L.P.
SC 13G · Sep 18, 2023
5.6%
3.7M shares
SC 13G/A · Feb 14, 2023
5.0%
2.7M shares
SC 13G · Feb 14, 2023
6.5%
3.5M shares
Biotechnology Value Fund, L.P.
SC 13G/A · Feb 14, 2023
2.7%
1.4M shares
SC 13G/A · Jan 31, 2023
7.3%
3.9M shares
SC 13D/A · Apr 25, 2022
10.0%
5.3M shares
SC 13D/A · Apr 21, 2022
10.0%
5.3M shares
SC 13G/A · Feb 14, 2022
4.0%
1.9M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares
SC 13G/A · Feb 11, 2022
5.7%
2.7M shares
Versant Venture Capital V, L.P.
SC 13G/A · Feb 11, 2022
0.8%
360K shares
SC 13G/A · Feb 10, 2022
4.2%
2.0M shares
SC 13G/A · Jan 10, 2022
7.8%
3.7M shares
DRIEHAUS CAPITAL MANAGEMENT LLC
SC 13G · Jan 10, 2022
10.1%
4.8M shares